$0.2481
-0.0009-0.36%
At close: Sep 2, 5:00 PM EST

Theriva Biologics (TOVX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.05 | $-0.05 | $-0.37 | $-0.38 |
| Actual | $-0.07 | $-0.05 | $-0.12 | $-0.45 |
| Surprise | -40.0% | 0.00% | +67.8% | -18.4% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $300000 | $0 | $0 |
| Surprise | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.07 | $-0.05 | -40.0 % |
| Q1 | May 5, 2026 | $-0.05 | $-0.05 | 0.00 % |
| Q4 | Mar 12, 2026 | $-0.12 | $-0.37 | 67.8 % |
| Q3 | Nov 12, 2025 | $-0.45 | $-0.38 | -18.4 % |